BABA
Alibaba Group Holding Limited
BABA's fundamentals are weak: its operating margin fell 10 points to 4.2% and free cash flow turned negative, though revenue grew 4.3%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
INVZ
Innoviz Technologies Ltd.
There isn't enough reported data to score INVZ yet.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
INVZ Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
INVZ's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
INVZ PE Valuation
INVZ has no meaningful PE right now: it lost money over the past year.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
INVZ Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect INVZ's losses to shrink, with revenue growing.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over INVZ in the latest year-over-year earnings comparison.
INVZ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$0.34 | +$0.23 |
| Q2 2025 | -$0.42 | +$0.25 |
| Q4 2024 | -$0.57 | +$0.27 |
| Q2 2024 | -$0.67 | +$0.32 |
| Q4 2023 | -$0.84 | +$0.10 |
| Q4 2022 | -$0.94 | +$0.60 |
INVZ is still losing money, but far less than before: $0.38 per share over the past year, against $1.54 at its worst in late 2021.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA's revenue has grown year over year for 16 quarters in a row: $40.2B last quarter, up 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over INVZ on profitability, with a higher operating margin.
INVZ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $37.3M | +144% |
| Q4 2025 | $12.7M | +20% |
| Q2 2025 | $27.1M | +98% |
| Q4 2024 | $10.5M | -43% |
| Q2 2024 | $13.7M | +454% |
| Q4 2023 | $18.4M | +649% |
| Q2 2023 | $2.5M | -31% |
| Q4 2022 | $2.5M | -55% |
INVZ has the edge over BABA in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -176% | +254 points |
| Q4 2025 | -165% | +247 points |
| Q3 2025 | -103% | +233 points |
| Q2 2025 | -114% | +2744 points |
| Q4 2024 | -431% | +2462 points |
| Q2 2024 | -412% | +1334 points |
| Q4 2023 | -336% | +2548 points |
| Q2 2023 | -2858% | N/A |
INVZ's operating margin was −176% last quarter, up 254 points from the same quarter a year ago.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
INVZ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$52.4M | -$38.4M |
| Q4 2025 | -$10.2M | +$26.5M |
| Q2 2025 | -$28M | +$16.7M |
| Q4 2024 | -$36.7M | +$6.4M |
| Q2 2024 | -$44.7M | +$11.9M |
| Q4 2023 | -$43.1M | +$17.8M |
| Q2 2023 | -$56.6M | -$1.4M |
| Q4 2022 | -$60.8M | +$25.5M |
INVZ has burned cash in almost every quarter: −$105M over the past year, against −$181M the year before.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has the edge over INVZ on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
INVZ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +19% | +38.8M shares |
| 1 year | +43% | +71.5M shares |
| 3 years | +84% | +109M shares |
INVZ has 239M diluted shares, up 43% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
INVZ Net Leverage
INVZ's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
INVZ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.0 | Oversold |
| Stochastic | 9.4 | Oversold |
INVZ's weekly RSI is 26 (oversold) and its Stochastic is 9 (oversold).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
INVZ PE vs Consumer Cyclical Sector
INVZ has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
INVZ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.27 | 30% below |
| 20 week MA | $0.38 | 50% below |
| 50 week MA | $0.66 | 71% below |
| 100 week MA | $1.01 | 81% below |
| 200 week MA | $1.49 | 87% below |
INVZ is in a downtrend: it's below all five of its weekly moving averages, and 87% below its 200-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has the edge over INVZ on returns for 2026, with the stronger performance.
INVZ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.92 | $15.5 | +56% |
| 2021 | $15.5 | $6.32 | -59% |
| 2022 | $6.32 | $3.72 | -41% |
| 2023 | $3.72 | $2.53 | -32% |
| 2024 | $2.53 | $1.80 | -29% |
| 2025 | $1.80 | $0.95 | -47% |
| 2026 YTD | $0.95 | $0.19 | -80% |
INVZ has finished five years in a row lower, and it's down 80% so far in 2026.